Documents from the FDA and Pfizer have revealed that shedding, or the release of viral or bacterial gene therapy products, does occur from individuals who have received the mRNA gene therapy products commonly referred to as the “covid vaccine.” This information, brought to light by the Front Line COVID-19 Critical Care Alliance (FLCCC), confirms the concerns of independent researchers who have been warning about this threat for years.
According to an FDA document from 2015 titled “Design and Analysis of Shedding Studies for Virus or Bacteria-Based Gene Therapy and Oncolytic Products,” shedding is defined as the release of these gene therapy products through excreta, secreta, or through the skin. The document further explains that gene therapy products are those that mediate their effects through the transfer of genetic material. Since both mRNA injections for COVID and adenovirus vaccines fall into this category, it is a clear admission from the FDA that fully vaccinated individuals shed these potentially harmful substances onto others through contact or close proximity.
Dr. Pierre Kory, speaking at a recent FLCCC conference in Phoenix, highlighted the risks associated with shedding. He stated that fully vaccinated individuals are contaminating others with spike proteins and other components of the vaccines, which have even been found in breast milk. The threat of shedding can persist for at least six months after vaccination, debunking claims that it is only a temporary occurrence.
Despite these findings, the FDA continues to deny the existence of shedding, stating that COVID vaccines are not regulated as gene therapy products. However, Pfizer's own literature acknowledges the risk of spreading the vaccine's components to others through inhalation or skin contact. The examples provided by Pfizer include male participants exposing female partners prior to or around conception and pregnant females reporting exposure through inhalation or skin contact.
There is also the concern of secondary shedding, where someone who was exposed to shedding through environmental contact then sheds it to another individual. This highlights the potential for the spread of these substances beyond the initial exposure.
The revelations regarding shedding from the COVID vaccine raise significant questions about the potential risks and consequences for both vaccinated and unvaccinated individuals. It is crucial for further research and investigation to be conducted to fully understand the implications of shedding and its impact on public health.
In conclusion, the FDA and Pfizer documents confirm the occurrence of shedding from individuals who have received the mRNA gene therapy products. This sheds light on the concerns raised by independent researchers regarding the potential risks associated with the COVID vaccine. The persistence of shedding for an extended period and the risk of secondary shedding further emphasize the need for continued research and vigilance in monitoring the effects of vaccination on both individuals and public health.
